retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Medscape | The investigational GLP-1/GIP/glucagon receptor produced significant weight loss and A1c reduction in people Retatrutide, the triple-G (GLP-1, GIP,
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21


























